Back to Results
First PageMeta Content
T helper cell / T cells / CD30 / Chimeric antigen receptor


Phase I Study of the Administration of EBV CTLs Expressing CD30 Chimeric Receptors (CAR.CD30) for Relapsed CD30+ Hodgkin Lymphoma and CD30+ Non-Hodgkin Lymphoma
Add to Reading List

Document Date: 2013-12-31 14:00:44

Open Document

File Size: 780,23 KB

Share Result on Facebook

Company

LTR SD SA / Monoclonal Antibody Tumor Ag / Ansell / /

MedicalCondition

Relapsed CD30+ Hodgkin Lymphoma / viral infection Do CD30 / disease / CH3-Cy5 CAR-CD30+ EBV-CTLs Efficiently Kill CD30+ Tumor Cells CAR-CD30 / Hodgkin’s Disease / /

MedicalTreatment

Molecular Therapy / /

Organization

Administration of EBV CTLs Expressing CD30 Chimeric Receptors / /

Person

Gianpietro Dotti / Carlos Ramos / Barbara Savoldo / /

Position

Clinical Investigator / /

SportsEvent

NHL / /

Technology

1034 Protocol / cell receptors / /

SocialTag